Ca-125, A Biomarker in Acute-Decompensated Heart Failure. Preliminary Study.

1. McMurray JJ V, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart. Rev Port Cardiol. 2013;32(7-8):e1--641--e61.doi:10.1093/eurheartj/ehs104.10.1093/eurheartj/ehs104Open DOISearch in Google Scholar

2. Ma J, Zhao Y,Wang Y, Guo Y, Li J. Tumor marker levels in patients aged 85 years and older with chronic heart failure. Eur J Intern Med. 2013;24(5):440-443. doi:10.1016/j.ejim.2013.04.002.10.1016/j.ejim.2013.04.002Open DOISearch in Google Scholar

3. Miñana G, Palau P, Núñez J, Sanchis J. The Tumor Marker CA125 and Heart Failure. Eur Heart J. 2010;31(14):1752-1763. doi:10.1093/eurheartj/ehq142.10.1093/eurheartj/ehq142Open DOISearch in Google Scholar

4. Turgut O, Tandogan I, Yilmaz MB, Gul I, Zorlu A. CA125 in heart failure: Implications for immunoinflammatory activity. Int J Cardiol. 2011;146(1):99-100. doi:10.1016/j.ijcard.2010.05.077.10.1016/j.ijcard.2010.05.077Open DOISearch in Google Scholar

5. Huang F, Zhang K, Chen J, et al. Elevation of carbohydrate antigen 125 in chronic heart failure may be caused by mechanical extension of mesothelial cells from serous cavity effusion. Clin Biochem. 2013;46(16-17):1694-1700. doi:10.1016/j.clinbiochem.2013.09.008.10.1016/j.clinbiochem.2013.09.008Open DOISearch in Google Scholar

6. Monteiro S, Franco F, Costa S, et al. Prognostic value of CA125 in advanced heart failure patients. Int J Cardiol. 2010;140(1):115-118. doi:10.1016/j.ijcard.2008.11.023.10.1016/j.ijcard.2008.11.023Open DOISearch in Google Scholar

7. Turgut O, Tandogan I, Yilmaz MB, Gul I, Gurlek A. CA125 levels among patients with advanced heart failure: An emerging independent predictor for survival. Int J Cardiol. 2010;145(1):71. doi:10.1016/j.ijcard.2009.04.030.10.1016/j.ijcard.2009.04.030Open DOISearch in Google Scholar

8. Zorlu A, Tandogan I, Yilmaz MB. CA-125, an omitted part of the heart. Hear Lung Circ. 2011;20(5):345. doi:10.1016/j.hlc.2011.01.025.10.1016/j.hlc.2011.01.025Search in Google Scholar

9. D’Aloia A, Faggiano P, Aurigemma G, et al. Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: Relation to clinical severity, hemodynamic and doppler echocardiographic abnormalities, and short-term prognosis. J Am Coll Cardiol. 2003;41(10):1805-1811. doi:10.1016/S0735-1097(03)00311-5.10.1016/S0735-1097(03)00311-5Search in Google Scholar

10. Núñez J, Miñana G, González M, et al. Antigen carbohydrate 125 in heart failure: Not just a surrogate for serosal effusions? Int J Cardiol. 2011;146(3):473-474. doi:10.1016/j.ijcard.2010.12.027.10.1016/j.ijcard.2010.12.027Search in Google Scholar

11. Nunez J, Llacer P, Nunez E, et al. Antigen carbohydrate 125 and creatinine on admission for prediction of renal function response following loop diuretic administration in acute heart failure. Int J Cardiol. 2014;174(3):516-523. doi:10.1016/j.ijcard.2014.04.113.10.1016/j.ijcard.2014.04.113Open DOISearch in Google Scholar

12. Núñez J, Núñez E, Sanchis J, et al. Antigen carbohydrate 125 and brain natriuretic peptide serial measurements for risk stratification following an episode of acute heart failure. Int J Cardiol. 2012;159(1):21-28. doi:10.1016/j.ijcard.2011.02.001.10.1016/j.ijcard.2011.02.001Open DOISearch in Google Scholar

13. Vizzardi E, D’Aloia A, Pezzali N, Bugatti S, Curnis A, Dei Cas L. Long-term prognostic value of CA 125 serum levels in mild to moderate heart failure patients. J Card Fail. 2012;18(1):68-73. doi:10.1016/j.cardfail.2011.09.012.10.1016/j.cardfail.2011.09.012Open DOISearch in Google Scholar

14. Miñana G, Palau P, Núñez J, Sanchis J. The Tumor Marker CA125 and Heart Failure. Rev Española Cardiol (English Ed. 2010;63(10):1213-1214. doi: 10.1016/S1885-5857(10)70240-1.10.1016/S1885-5857(10)70240-1Search in Google Scholar

15. Yilmaz MB, Nikolaou M, Solal AC. Tumour biomarkers in heart failure: Is there a role for CA-125? Eur J Heart Fail. 2011;13(6):579-583. doi:10.1093/eurjhf/hfr022.10.1093/eurjhf/hfr022Open DOISearch in Google Scholar

16. Topatan B, Basaran A. CA-125 and heart failure: Deja vu or “still to be seen.” Int J Cardiol. 2010;145(3):626-629. doi:10.1016/j.ijcard.2010.09.060.10.1016/j.ijcard.2010.09.060Open DOISearch in Google Scholar

17. Huang F, Chen J, Liu Y, Zhang K, Wang J, Huang H. New mechanism of elevated CA125 in heart failure: The mechanical stress and inflammatory stimuli initiate CA125 synthesis. Med Hypotheses. 2012;79(3):381-383. doi:10.1016/j.mehy.2012.05.042.10.1016/j.mehy.2012.05.042Open DOISearch in Google Scholar

18. Napan S, Aussawapokee T, Nargileci E, Qureshi A, Khadra S, Stroger JH. Prognostic Significance of Carbohydrate Antigen 125 in Patients With Heart Failure and Preserved Ejection Fraction. J Am Coll Cardiol. 2010;55(10):A30.E292. doi:10.1016/S0735-1097(10)60293-8.10.1016/S0735-1097(10)60293-8Search in Google Scholar

19. Nunez J, Minana G, Nunez E, Sanchis J. Antigen carbohydrate 125 in heart failure: A promising clinical tool. Int J Cardiol. 2011;150(3):369-370. doi:10.1016/j.ijcard.2011.05.089.10.1016/j.ijcard.2011.05.089Open DOISearch in Google Scholar

20. Sánchez-Marteles M, Rubio Gracia J, Giménez López I. Pathophysiology of acute heart failure: a world to know. Rev Clin Esp. 2015;216(1):38-46. doi:10.1016/j.rce.2015.09.010.10.1016/j.rce.2015.09.010Open DOISearch in Google Scholar

21. Nunez J, Merlos P, Facila L, et al. Prognostic effect of carbohydrate antigen 125-guided therapy in patients recently discharged for acute heart failure (CHANCEHF). Study design. [Spanish]. Rev Esp Cardiol. 2015;68(2):121-128. doi:http://dx.doi.org/10.1016/j.recesp.2014.03.018.10.1016/j.recesp.2014.03.018Open DOISearch in Google Scholar